Tokyo, Oct. 26 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000059384) titled 'A Study on the Effects of Continued Consumption of the Test Food on Immune and Aging Markers' on Oct. 25.
Study Type:
Interventional
Study Design:
Basic Design - Parallel
Randomization - Randomized
Blinding - Double blind -all involved are blinded
Control - Placebo
Primary Sponsor:
Institute - IMEQRD Co. Ltd.
Condition:
Condition - Healthy adults
Classification by malignancy - Others
Genomic information - NO
Objective:
Narrative objectives1 - To evaluate the effects of continuous intake of the test food on immune and aging markers in adult men and women.
Basic objectives2 - Safety,Efficacy
Intervention:
Interventions/Control_1 - The test food is taken every day.
Interventions/Control_2 - The placebo food is taken every day.
Eligibility:
Age-lower limit - 20
years-old
Gender - Male and Female
Key inclusion criteria - 1. Age 20 to under 70
2. Japanese men and women
3. BMI >=18.5 kg/m^2 and =40g pure alcohol per day)
14. Plans for overseas travel during the study
15. Pregnant, breastfeeding, or planning pregnancy during the study
16. Blood donation of >200ml within 1 month or >400ml within 3 months prior to screening
17. Participation in another clinical study within 1 month prior to consent, currently participating, or planning to participate during the study
18. Deemed unsuitable for participation by the principal investigator
Target Size - 60
Recruitment Status:
Recruitment status - Preinitiation
Date of protocol fixation - 2025 Year 08 Month 27 Day
Anticipated trial start date - 2025 Year 12 Month 18 Day
Last follow-up date - 2026 Year 03 Month 13 Day
To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000067920
Disclaimer: Curated by HT Syndication.
